These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23565287)

  • 61. Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration.
    Reyes-Cabello C; Alen F; Gómez R; Serrano A; Rivera P; Orio L; Rodríguez de Fonseca F; Pavón FJ
    Pharmacol Biochem Behav; 2012 Mar; 101(1):1-7. PubMed ID: 22133635
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats.
    Varga B; Kassai F; Gyertyán I
    Pharmacol Biochem Behav; 2012 Dec; 103(2):425-30. PubMed ID: 23026059
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.
    Tallett AJ; Blundell JE; Rodgers JR
    Behav Pharmacol; 2007 Nov; 18(7):591-600. PubMed ID: 17912043
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cannabinoid receptor type-1 partially mediates metabolic endotoxemia-induced inflammation and insulin resistance.
    Grunewald ZI; Lee S; Kirkland R; Ross M; de La Serre CB
    Physiol Behav; 2019 Feb; 199():282-291. PubMed ID: 30502357
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.
    Thornton-Jones ZD; Vickers SP; Clifton PG
    Psychopharmacology (Berl); 2005 May; 179(2):452-60. PubMed ID: 15821957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Central cannabinoid signaling mediating food intake: a pharmacological-challenge magnetic resonance imaging and functional histology study in rat.
    Dodd GT; Stark JA; McKie S; Williams SR; Luckman SM
    Neuroscience; 2009 Nov; 163(4):1192-200. PubMed ID: 19607884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endocannabinoid control of food intake and energy balance.
    Di Marzo V; Matias I
    Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The interaction between ghrelin and cannabinoid systems in penicillin-induced epileptiform activity in rats.
    Arslan G; Ayyildiz M; Agar E
    Neuropeptides; 2014 Dec; 48(6):345-52. PubMed ID: 25256087
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats.
    Tallett AJ; Blundell JE; Rodgers RJ
    Pharmacol Biochem Behav; 2009 Jan; 91(3):358-66. PubMed ID: 18755211
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ghrelin modulates the fMRI BOLD response of homeostatic and hedonic brain centers regulating energy balance in the rat.
    Sárvári M; Kocsis P; Deli L; Gajári D; Dávid S; Pozsgay Z; Hegedűs N; Tihanyi K; Liposits Z
    PLoS One; 2014; 9(5):e97651. PubMed ID: 24830778
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of combined oleoyl-estrone and rimonabant on overweight rats.
    Ferrer-Lorente R; Cabot C; Fernández-López JA; Alemany M
    J Pharmacol Sci; 2007 Jun; 104(2):176-82. PubMed ID: 17558182
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.
    Mathes CM; Ferrara M; Rowland NE
    Am J Physiol Regul Integr Comp Physiol; 2008 Jul; 295(1):R67-75. PubMed ID: 18448611
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.
    Dore R; Valenza M; Wang X; Rice KC; Sabino V; Cottone P
    Addict Biol; 2014 Sep; 19(5):849-61. PubMed ID: 23587012
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice.
    Pang Z; Wu NN; Zhao W; Chain DC; Schaffer E; Zhang X; Yamdagni P; Palejwala VA; Fan C; Favara SG; Dressler HM; Economides KD; Weinstock D; Cavallo JS; Naimi S; Galzin AM; Guillot E; Pruniaux MP; Tocci MJ; Polites HG
    Obesity (Silver Spring); 2011 Oct; 19(10):1923-34. PubMed ID: 21799481
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats.
    Dyr W; Ligieza J; Kostowski W
    Alcohol; 2008 Sep; 42(6):509-12. PubMed ID: 18504086
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats.
    Jones EK; Kirkham TC
    Br J Pharmacol; 2012 Jul; 166(6):1815-21. PubMed ID: 22309979
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats.
    Need AB; Davis RJ; Alexander-Chacko JT; Eastwood B; Chernet E; Phebus LA; Sindelar DK; Nomikos GG
    Psychopharmacology (Berl); 2006 Jan; 184(1):26-35. PubMed ID: 16328376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
    Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.